Date: Tuesday, May 14, 2024
Time: 2:00pm – 3:00pm ET

TITLE:
Hemophilia Alliance Network Services/Emerging Therapy Solutions

A Gene Therapy Payer Contract

WEBINAR DESCRIPTION:
The past twelve to eighteen months have been landmark times for gene therapy treatments for individuals with bleeding disorders. While the third party payers, reinsurers and prescription benefit plans have begun forming strategies for benefit plan coverage, pricing, patient qualifications and follow up reporting. Hemophilia Alliance Network Services (HANS) has been hard at work arranging for adequate contractual arrangements with important entities influencing Payor behavior and strategies for the use of Gene Therapy. The HANS goal was to create relationships with entities that could offer acceptable contractual terms but importantly influence the common prior authorization process to provide a clear path for delivery of the product, provision of the service to Hemophilia Treatment Center (HTC) patients, and subsequent confidence in the payment for this high-cost therapy.

HANS is pleased to announce that it has executed an Agreement with Emerging Therapy Solutions (ETS) effective January 1, 2024. Emerging Therapy Solutions® (ETS), an industry leader in providing cutting-edge services to help payers and other risk-bearing entities prepare for the accelerating growth in cell and gene therapies and other high-cost, complex treatments. This webinar will provide a high-level overview from HANS leadership regarding the Agreement with ETS as well as how HTCs can gain access to this Agreement. HANS will ask the leadership from ETS to describe the business model and services they provide, the ETS customer base and provide important information on how to HTCs can intersect with ETS to obtain necessary approvals for gene therapy treatments for qualified patients. During this one-hour webinar you will hear important details on the authorization process, clinical review and administrative details that provide a clearer path to benefit coverage and payment for HTC patients rather than the time-consuming process of single case agreements with payors that many HTCs have experienced thus far.

This webinar is available to ALL Hemophilia Treatment Centers that are members of the Hemophilia Alliance, it is NOT restricted to participating members of the Hemophilia Alliance Network Services Agreements. If an HTC is not a HANS member today and wishes to join HANS to access the ETS agreement , please reach out to your Member and Community Relations Team Member who will assist you. Administrators, Finance team members, Pharmacists and Physicians are ideal candidates to attend this webinar. However, it is open to any interested employee of member HTCs.

SPEAKERS & BIOs:

Roland Lamy, Jr. – Vice President of Payer Relations
Roland Lamy has held a variety of leadership positions in the healthcare industry including sales management, underwriting, employee benefit and rate development, hospital and physician negotiations and contracting, and government programs oversight and business management. Click here to learn more about Roland…

Zack Duffy – Director of Member & Community Relations
Most recently, Zack Duffy was the Program Administrator for The Hemophilia Center at Oregon Health & Science University (OHSU) overseeing the administrative and business functions of the clinic and pharmacy. He started with the Factor Program at The Hemophilia Center in 2013, when it was a 340B physician dispense model. In 2017, he led the transition from a physician dispense to a pharmacy dispensing model. Click here to learn more about Zack…